1-4 of 4
Hailing Liu
Close
Sort by
Journal Articles

Pomalidomide, Rituximab, Orelabrutinib, and Minichop-like (PRO-miniCHOP) in Elderly Patients with Newly Diagnosed Diffuse Large-B Cell Lymphoma: Preliminary Results from a Phase II Study

Nana Ping, Changju Qu, Jiajie He, Hailing Liu, Rui Zou, Qian Zhu, Xiao Zhang, Depei Wu, Zhengming Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6238.
https://doi.org/10.1182/blood-2023-181350
Published: 2023
Journal Articles

High Rates of Remission with the Initial Treatment of Oral Selinexor Plus CHOP for Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes Analysis of a Multi-Center Phase II Study in China

Kaiyang Ding, Jie Ma, Xiaohui Zhang, Chunling Wang, Huang Hongming, Lixia Sheng, Hailing Liu, Lei Cao, Wei Wu, Jianyong Li, Lei Fan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1696.
https://doi.org/10.1182/blood-2023-182553
Published: 2023
Journal Articles

The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma

Kaiyang Ding, Xiao Shi, Haiyan Yang, Lei Cao, Xiaoli Zhao, Hailing Liu, Wei Wu, Xiaoyan Zhang, Li Wang, Wei Xu, Huayuan Zhu, Jianyong Li, Lei Fan
Journal: Blood
Blood (2021) 138 (Supplement 1): 2461.
https://doi.org/10.1182/blood-2021-150523
Published: 2021
Journal Articles

Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial

Kaiyang Ding, Hailing Liu, Haiyan Yang, Lei Cao, Xiaoli Zhao, Wei Wu, Xiaoyan Zhang, Li Wang, Wei Xu, Huayuan Zhu, Jianyong Li, Lei Fan
Journal: Blood
Blood (2021) 138 (Supplement 1): 1385.
https://doi.org/10.1182/blood-2021-150145
Published: 2021